Management of symptomatic adenomyosis in patients who desire future childbearing

LNG 52 IUD: 52 mg levonorgestrel-releasing intrauterine device; NSAIDs: nonsteroidal antiinflammatory drugs; GnRH: gonadotropin-releasing hormone.

* NSAIDs are effective treatments for heavy menstrual bleeding and dysmenorrhea. NSAID types, doses, and contraindications for use are discussed in detail in related UpToDate content.

¶ Data on adenomyosis treatment were generated based on the 52 mg system, thus other LNG IUDs (ie, LNG 19.5, LNG 13.5) are not typically used as treatment for patients with adenomyosis.

Δ Candidates and contraindications to the LNG 52 are discussed in related UpToDate content.

◊ Symptoms typically begin to improve by three to six months after IUD placement or starting alternative hormone therapy.